14 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

MILLENNIUM 9000 PHASED ARRAY NEUROVASCULAR COIL

FDA 510(k)
FDA Class 2 ·Radiology

Implant Prosthetics

FDA UDI
Preat Corporation·00842092104446·Biomet 3i Certain®-compatible 5.0mm Esthetic Ab...

Cortera

FDA UDI
Xtant Medical Holdings, Inc.·00810076562186·Rod Gripper, 5.5-6.0

RADIOMED SOURCE

FDA 510(k)
FDA Class 2 ·Radiology

KM-10 TENS ELECTRODE

FDA 510(k)
FDA Class 2 ·Neurology

PICC NATE

FDA Adverse Event
Injury ·UTAH MEDICAL PRODUCTS, INC.·Product code LJS·January 12, 2007

PICC NATE

FDA Adverse Event
Injury ·UTAH MEDICAL PRODUCTS, INC.·Product code LJS·January 12, 2007

9800

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS (SLC)·Product code JAA·February 12, 2013

HOMECHOICE PRO

FDA Adverse Event
Malfunction ·BAXTER HEALTHCARE - LARGO·Product code FKX·February 25, 2011

VAPR SE ELECTRODE

FDA Adverse Event
Malfunction ·DEPUY MITEK·Product code GEI·February 25, 2008

PICC-NATE

FDA Adverse Event
Injury ·UTAH MEDICAL PRODUCTS·Product code DQO·April 28, 2004

Boston Scientific/Cameron Health SQ-RX Model 1010 subcutaneous pulse generators. The S-ICD System is intended to provide therapy for the treatment of life-threatening ventricular tachyarrhythmias.

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·March 27, 2013

CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024

Quadra Assura, Model No. CD3265-40, CD3265-40Q, CD3365-40C, CD3365-40Q. Quadra Assura MP, Model No. CD3269-40, CD3269-40Q, CD3369-40C. Fortify and Fortify Assura implantable cardioverter defibrillators (ICDS) are intended to provided ventricular anti-tachycardia pacing and ventricular defibrillation for automated treatment of life threatening ventricular arrhythmias. The devices may also be programmed to provide single or dual chamber bradycardia pacing. Unify and Unify Assura cardiac resynchronization therapy defibrillators (CRTDs) are intended to provide ventricular anti-tachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. The devices may also be programmed to provide single or dual chamber bradycardia pacing, in additional to cardiac resynchronization therapy via left ventricular pacing

FDA Enforcement
Class I ·Terminated·St Jude Medical Inc.·November 2, 2016